426
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Influence of Prosthodontic Rehabilitation Using Zygomatic Implants in Covid 19 Related Mucormycosis (Rhino–Orbital–Cerebral) Maxillectomy Patients Upon Post-Operative Stress, Anxiety and Functional Impairment: A Prospective Cohort Study

, , , ORCID Icon, , ORCID Icon, , & show all
Pages 1201-1219 | Received 16 Mar 2023, Accepted 20 Jul 2023, Published online: 01 Aug 2023

References

  • Agarwala P, Bhargava A, Gahwai DK, Negi SS, Shukla P, Dayama S. Epidemiological characteristics of the COVID-19 Pandemic during the first and second waves in Chhattisgarh, Central India: a comparative analysis. Cureus. 2022;14(4):56.
  • Fürbringer P. Beobachtungen über Lungenmycose beim Menschen. Virchows Arch. 1876;66:330–365.
  • Sommer AP, Försterling HD, Naber KG, Pitchappan RM. Pulmonary and intranasal delivery of thymoquinone-loaded nanoparticles for Mucormycosis & Covid-19. Precision Nanomed. 2021;4(2):795–800.
  • Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi. 2020;6(4):265.
  • Revannavar SM, Supriya PS, Samaga L, Vineeth V. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?. BMJ Case Reports CP. 2021;14(4):e241663.
  • Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26–34.
  • Patel A, Kaur H, Xess I, et al. A multicenter observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020;26(7):944–e9.
  • Lanternier F, Dannaoui E, Morizot G, et al.; French Mycosis Study Group. A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007). Clin Infect Dis. 2012;54(suppl_1):S35–43.
  • Kontoyiannis DP, Lewis RE. How I treat mucormycosis. Blood J Am Soc Hematol. 2011;118(5):1216–1224.
  • Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin Infect Dis. 2012;54(suppl_1):S44–54.
  • Sen M, Honavar SG, Bansal R, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India–Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021;69(7):1670.
  • Jose A, Singh S, Roychoudhury A, Kholakiya Y, Arya S, Roychoudhury S. Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: a comprehensive review. J Maxillofac Oral Surg. 2021;20(3):373–380.
  • Jones AC, Bentsen TY, Freedman PD. Mucormycosis of the oral cavity. Oral Surg Oral Med Oral Pathol. 1993;75:455–460.
  • Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405–21.
  • Groll AH, Pana D, Lanternier F, et al. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol. 2021;22(6):e254–69.
  • Said Ahmed WM, Elsherbini AM, Elsherbiny NM, El-Sherbiny M, Ramzy NI, Arafa AF. Maxillary mucormycosis osteomyelitis in post COVID-19 patients: a series of fourteen cases. Diagnostics. 2021;11(11):2050.
  • Mattoo K, Singh M, Rahman S. Rehabilitation of disfigurement associated with maxillectomy by a cheek plumper prosthesis. Am J Med Case Rep. 2014;2(10):200–203.
  • Kumari A, Rao NP, Patnaik U, et al. Management outcomes of mucormycosis in COVID-19 patients: a preliminary report from a tertiary care hospital. Med J Armed Forces India. 2021;77:S289–95.
  • Brånemark PI, Gröndahl K, Öhrnell LO, et al. Zygoma fixture in the management of advanced atrophy of the maxilla: technique and long‐term results. Scandinavian J Plastic Reconstructive Surg Hand Surgery. 2004;38(2):70–85.
  • Butterworth CJ. Primary vs. Secondary zygomatic implant placement in patients with head and neck cancer—A 10‐year prospective study. Head Neck. 2019;41(6):1687–1695.
  • Boyes-Varley JG, Howes DG, Davidge-Pitts KD, Brånemark PI, McAlpine JA. A protocol for maxillary reconstruction following oncology resection using zygomatic implants. Int J Prosthodontics. 2007;20(5):65.
  • Cerea M, Dolcini GA. (2018) Custom-made direct metal laser sintering titanium sub periosteal implants: a retrospective clinical study on 70 patients. Biomed Res Int. 2018;1–11.
  • Davó R, David L. Quad Zygoma Protocol. Atlas Oral Maxillofac Surg Clin North Am. 2021;29(2):243–251.
  • Schmidt BL, Pogrel MA, Young CW, Sharma A. Reconstruction of extensive maxillary defects using zygomaticus implants. J Oral Maxillofacial Surgery. 2004;62:82–89.
  • Brown JS, Rogers SN, McNally DN, Boyle M. A modified classification for the maxillectomy defect. Head Neck. 2000;22(1):17–26.
  • Al Makramani BMA, Al Sanabani F, Mattoo KA. Reviewing infection control in prosthodontic practice with a case of herpes simplex in the times of a coronavirus pandemic. Ann Romanian Soc Cell Biol. 2021;25(6):10898–10904.
  • Mattoo KA, Jain S. Managing prosthodontic (geriatric) patients during the SARS-CoV-2 pandemic. J Int Oral Health. 2020;12:S69–75.
  • Degidi M, Nardi D, Piattelli A. Immediate loading of the edentulous maxilla with a definitive restoration supported by an intraorally welded titanium bar and tilted implants. Int J Oral Maxillofac Implants. 2010;25:1175–1182.
  • Mattoo K, Singh SP, Brar A. A simple technique to align attachment components in implant supported mandibular overdenture. Int J Res Med Sci Technol. 2014;1(1):6–8.
  • Sindi AS, Mittal R, Mattoo K, et al. Impact of an Auditory Mediated Patient Health Education (PHE) Program on Treatment Compliance and Satisfaction Among Patients Seeking Prosthodontic Care During COVID Pandemic–A Prospective Interventional Study. Patient Prefer Adherence. 2022;16:1247–1255.
  • Adam EK, Quinn ME, Tavernier R, McQuillan MT, Dahlke KA, Gilbert KE. Diurnal cortisol slopes and mental and physical health outcomes: a systematic review and meta-analysis. Psychoneuroendocrinology. 2017;83:25–41.
  • Arafah BM, Nishiyama FJ, Tlaygeh H, Hejal R. Measurement of Salivary Cortisol Concentration in the Assessment of Adrenal Function in Critically Ill Subjects: a Surrogate Marker of the Circulating Free Cortisol. J Clin Endocrinol Metab. 2007;92:2965–2971.
  • Veale D, Eshkevari E, Kanakam N, Ellison N, Costa A, Werner T. The Appearance Anxiety Inventory: validation of a Process Measure in the Treatment of Body Dysmorphic Disorder. Behav Cogn Psychother. 2014;42:605–616.
  • Mastro S, Zimmer-Gembeck MJ, Webb HJ, Farrell L, Waters A. Young adolescents’ appearance anxiety and body dysmorphic symptoms: social problems, self-perceptions and comorbidities. J Obsessive Compuls Relat Disord. 2016;8:50–55.
  • Ohara A, Tsukiyama Y, Ozawa T, Koyano K. A simplified sieve method for determining masticatory performance using hydrocolloid material. J Oral Rehabil. 2003;30:927–935.
  • Gonçalves TM, Sanchez-Ayala A, Ambrosano GM, Garcia RC. Female hormonal fluctuation and masticatory function in patients with disc displacement-a case-control study. Int J Prosthodont. 2011;24(4):320–327.
  • Kent RD. Hearing and believing: some limits to the auditory-perceptual assessment of speech and voice disorders. Am J Speech Language Pathol. 1996;5(3):7–23.
  • Asal S, Hassan S. Speech Assessment in Patients Rehabilitated with Obturators Lined with New Permanent Soft Liner. Egypt Dent J. 2011;57(649):659.
  • Kotby MN, Haleem EK, Hegazy M, Safe I, Zaki M. Aspects of assessment and management of VP dysfunction in developing countries. Folia Phoniatrica and Logopedica. 1997;49:139–146.
  • Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID‑19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021.
  • Mohan A, Tiwari P, Bhatnagar S, et al. Clinico‑demographic profile and hospital outcomes of COVID‑19 patients admitted at a tertiary care centre in north India. Indian J Med Res. 2020;152:61‑9.
  • Sridhara SR, Paragache G, Panda NK, Chakrabarti A. Mucormycosis in immunocompetent individuals: an increasing trend. J Otolaryngol. 2005;34:402–406.
  • Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020;185(4):599–606.
  • Mattoo K, Jain K. Speech enhancing prosthesis for acquired cleft palate. J Med Sci Clin Res. 2015;3(2):4396–4399.
  • Kumar L, Rao J, Mattoo KA, Yadav A. Finger prosthesis with an alternative approach. J Coll Phys Surg Pak. 2012;22(01):58–60.
  • Chrcanovic BR, Albrektsson T, Wennerberg A. Survival and complications of zygomatic implants: an updated systematic review. J Oral Maxillofacial Surgery. 2016;74(10):1949–1964.
  • Lacroix T, Jaby P, Nokovitch L, Chaux-Bodard AG. Prosthetic rehabilitation with zygomatic implants after maxillectomy: a systematic review. J Dent Oral Disord. 2020;6:1132.
  • Migliorança RM, Irschlinger AL, Peñarrocha-Diago M, Fabris RR, Javier AV, Zotarelli Filho IJ. History of zygomatic implants: a systematic review and meta-analysis. Dent Oral Craniofac Res. 2019;5:1–9.
  • Fouladi DB, Nassiri P, Monazzam EM, Farahani S, Hassanzadeh G, Hoseini M. Industrial Noise Exposure and Salivary Cortisol in Blue Collar Industrial Workers. Noise Health. 2012;14:184–189.
  • Lebel S, Castonguay M, Mackness G, Irish J, Bezjak A, Devins GM. The psychosocial impact of stigma in people with head and neck or lung cancer. Psycho‐oncology. 2013;22(1):140–152.
  • Irish J, Sandhu N, Simpson C, et al. Quality of life in patients with maxillectomy prostheses. Head Neck. 2009;31(6):813–821.
  • Silveira AP, Gonçalves J, Sequeira T, et al. Patient reported outcomes in head and neck cancer: selecting instruments for quality of life integration in clinical protocols. Head Neck Oncol. 2010;2:32.
  • Kosaka M, Sumita YI, Otomaru T, Taniguchi H. Differences of salivary cortisol levels between long-term and short-term wearers of dento-maxillary prosthesis due to head and neck cancer resection. J Prosthodont Res. 2014;58(1):41–47.
  • Kosaka M, Sumita YI, Taniguchi H, Suzuki T, Sasaki K. Evaluation of salivary cortisol levels in relation to dento-maxillary prosthesis adjustment. J Prosthodont Res. 2019;63(1):73–77.
  • Rogers SN, Lakshmiah SR, Narayan B, et al. A comparison of the long-term morbidity following deep circumflex iliac and fibula free flaps for reconstruction following head and neck cancer. Plast Reconstr Surg. 2003;112(6):1517–1525.
  • Landes CA. Zygoma implant‐supported midfacial prosthetic rehabilitation: a 4‐year follow‐up study including assessment of quality of life. Clin Oral Implants Res. 2005;16(3):313–325.
  • Wang F, Huang W, Zhang C, Sun J, Qu X, Wu Y. Functional outcome and quality of life after a maxillectomy: a comparison between an implant supported obturator and implant supported fixed prostheses in a free vascularized flap. Clin Oral Implants Res. 2017;28(2):137–143.
  • Buurman DJ, Speksnijder CM, Engelen BH, Kessler P. Masticatory performance and oral health‐related quality of life in edentulous maxillectomy patients: a cross‐sectional study to compare implant‐supported obturators and conventional obturators. Clin Oral Implants Res. 2020;31(5):405–416.
  • Matsuyama M, Tsukiyama Y, Tomioka M, Koyano K. Subjective assessment of chewing function of obturator prosthesis wearers. Int J Prosthodontics. 2007;20(1):56.
  • Ozaki H, Sakurai H, Yoshida Y, Yamanouchi H, Iino M. Oral Rehabilitation of Oral Cancer Patients Using Zygomatic Implant-Supported Maxillary Prostheses with Magnetic Attachment: three Case Reports. Case Rep Dent. 2018;2018:1694063.
  • de Rossi M, Palinkas M, Lucas B, et al. Masticatory muscle activity evaluation by electromyography in subjects with zygomatic implants. Med Oral Patol Oral Cir Bucal. 2017;22(3):e392.
  • Rieger J, Wolfaardt J, Seikaly H, Jha N. Speech outcomes in patients rehabilitated with maxillary obturator prostheses after maxillectomy: a prospective study. Int J Prosthodontics. 2002;15(2):4565.
  • Bothur S, Garsten M. Initial speech problems in patients treated with multiple zygomatic implants. Int J Oral Maxillofacial Implants. 2010;25(2):89.
  • Gheorghiade M, Konstam MA, Burnett JC, et al. Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Short term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA. 2007;297:1332–1343.